HELLP syndrome with and without eclampsia

Sharon D Keiser1, Michelle Y Owens, Marc R Parrish

  • 1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Winfred L. Wiser Hospital for Women and Infants, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, USA.

Insights

This study found that concurrent eclampsia did not significantly worsen maternal or perinatal outcomes for patients with HELLP syndrome (hemolysis, elevated liver enzymes, low platelet count). Eclampsia does not appear to adversely impact HELLP syndrome pregnancies.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Critical Care Medicine

Background:

  • HELLP syndrome (hemolysis, elevated liver enzymes, low platelet count) is a severe obstetric complication.
  • Concurrent eclampsia in HELLP syndrome pregnancies is a concern for maternal and perinatal outcomes.

Purpose of the Study:

  • To compare pregnancy outcomes in patients with HELLP syndrome with and without concurrent eclampsia.
  • To determine if eclampsia significantly impacts maternal or perinatal outcomes in HELLP syndrome cases.

Main Methods:

  • Retrospective analysis of data from 1981-1996 and 2000-2006.
  • Inclusion of patients with class 1 or 2 HELLP syndrome.
  • Comparison of outcomes between HELLP syndrome with eclampsia (HELLP + E) and HELLP syndrome without eclampsia groups.

Main Results:

  • A total of 693 patients with HELLP syndrome were analyzed, with 70 having concurrent eclampsia.
  • The only significant demographic difference was greater nulliparity in the HELLP + E group.
  • No significant worsening of maternal or perinatal outcomes was detected in the HELLP + E group compared to the HELLP-only group.

Conclusions:

  • Concurrent eclampsia does not appear to significantly worsen maternal or perinatal outcomes in HELLP syndrome pregnancies.
  • In this cohort, eclampsia did not contribute an adverse impact on the course or outcome of HELLP syndrome pregnancies.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...